SEC 13F Intelligence

Vestcor Inc / ALXN

Vestcor Inc’s Alexion Pharmaceuticals Inc Position

Does Vestcor Inc own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 82.7K shares worth $15M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q2 2021
Shares
82.7K
% of Portfolio
+0.51%
Quarters Held
7
position exited

Position History ALXN

Reported value by quarter
Q4 ’19: $415,000Q4 ’19Q1 ’20: $425,000Q1 ’20Q2 ’20: $1MQ2 ’20Q3 ’20: $1MQ3 ’20Q4 ’20: $10MQ4 ’20Q1 ’21: $13MQ1 ’21Q2 ’21: $15MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202182.7K$15M+0.51%
Q1 202183.1K$13M+0.48%
Q4 202062.1K$10M+0.40%
Q3 202012.8K$1M+0.07%
Q2 202012.8K$1M+0.07%
Q1 20204.7K$425,000+0.02%
Q4 20193.8K$415,000+0.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vestcor Inc’s full portfolio or all institutional holders of ALXN.